Quick answer: NAD+ (nicotinamide adenine dinucleotide) is the central currency of cellular energy metabolism — it declines by approximately 50% between age 40 and 60 and this decline drives mitochondrial dysfunction, accelerated aging, and reduced DNA repair capacity. NMN and NR are the two NAD+ precursors with human clinical data. But the evidence for NAD+ precursor supplementation in healthy adults is substantially weaker than the viral podcast hype suggests — and the lifestyle interventions that raise NAD+ most effectively cost almost nothing.
NAD+ became a household longevity term after David Sinclair’s work on sirtuins, the publication of “Lifespan,” and a cascade of Joe Rogan appearances featuring NMN supplements. The underlying biology is real and important. The leap from “NAD+ declines with age and this matters for longevity” to “therefore take 500 mg of NMN daily” is substantially less supported than the marketing suggests.
Here is what I believe after reviewing the literature: NAD+ biology is one of the most promising areas in longevity science. The free lifestyle interventions that raise NAD+ (exercise, fasting, heat, adequate niacin) have strong evidence. The precursor supplements (NMN, NR) have promising but incomplete human data — they raise blood NAD+, and some studies show tissue-level and functional benefits, but we don’t yet have convincing human outcome data for longevity endpoints. The safety profile appears good. The price-to-evidence ratio is poor relative to the lifestyle interventions.
Welcome to The Private Practice. I am Dr. Tom, and I test all of this on myself first. Here is the complete picture.
What NAD+ Is and Why It Matters
NAD+ (oxidized form) and NADH (reduced form) are the primary electron carriers in cellular metabolism. Every cell in your body uses NAD+ as the electron acceptor in glycolysis and the citric acid cycle — transferring electrons from food molecules to the electron transport chain where ATP is produced. Without adequate NAD+, the mitochondrial electron transport chain slows, ATP production declines, and cells become energetically stressed.
NAD+ has additional roles beyond energy metabolism:
Sirtuins: The Longevity Proteins
Sirtuins (SIRT1–7) are NAD+-dependent deacetylases that regulate DNA repair, gene expression, inflammation, and mitochondrial biogenesis. SIRT1 and SIRT3 specifically require NAD+ as a substrate — they consume one NAD+ molecule per deacetylation reaction. This means that as NAD+ declines with age, sirtuin activity declines proportionally. SIRT1 regulates PGC-1alpha (the same mitochondrial biogenesis pathway activated by Zone 2 training), DNA repair proteins, and the inflammatory NF-kB pathway. SIRT3 regulates mitochondrial protein acetylation status, with declining SIRT3 activity producing the mitochondrial dysfunction characteristic of aging.
PARP Enzymes and DNA Repair
PARP (poly-ADP ribose polymerase) enzymes use NAD+ as a substrate to repair DNA damage. DNA double-strand breaks occur thousands of times per cell per day and must be continuously repaired. PARP is one of the primary repair mechanisms. With age, DNA damage accumulates faster (more oxidative stress, less antioxidant defense) while PARP activity declines (less NAD+ available). This combination drives the progressive DNA damage burden associated with aging and cancer risk. Restoring NAD+ availability may improve DNA repair capacity — a mechanism distinct from the sirtuin pathway.
The Age-Related NAD+ Decline
Multiple studies have documented a 50% decline in tissue NAD+ levels between the 3rd and 6th decades of life in humans and animal models. The mechanism is twofold: increased NAD+ consumption (more DNA damage requiring PARP repair, more inflammatory CD38 enzyme activity) and reduced NAD+ biosynthesis (declining NAMPT activity, the rate-limiting enzyme in the salvage pathway). The CD38 finding is important: CD38 is an enzyme that degrades NAD+ and is upregulated by chronic inflammation — the same inflammatory pathway driven by visceral fat and gut dysbiosis discussed in chronic inflammation. Addressing chronic inflammation is therefore directly relevant to NAD+ preservation.
NMN vs. NR: What the Human Studies Show
Both NMN (nicotinamide mononucleotide) and NR (nicotinamide riboside) are NAD+ precursors that enter the salvage biosynthesis pathway at different points. Both have been shown in human trials to raise blood NAD+ levels — but raising blood NAD+ is not the same as raising tissue NAD+ in relevant compartments (muscle, brain, liver).
NR (Nicotinamide Riboside)
NR has the longest human trial track record. A 2018 Cell Metabolism study by Elhassan et al. found that NR (1,000 mg/day for 6 weeks) significantly increased whole blood NAD+ and its metabolites in healthy middle-aged and older adults. A 2022 Nature Aging study found that NR supplementation in older adults improved mitochondrial function in skeletal muscle and reduced circulating inflammatory markers. However, a 2023 JAMA Network Open study of NR in patients with heart failure found no improvement in clinical outcomes — raising the question of whether blood NAD+ elevation translates to clinical benefit in disease states.
NMN (Nicotinamide Mononucleotide)
NMN has slightly more recent human data. A 2021 Science study by Yoshino et al. found that NMN (250 mg/day for 10 weeks) improved skeletal muscle insulin sensitivity and muscle gene expression related to energy metabolism in overweight, insulin-resistant postmenopausal women — the most compelling clinical human data for NMN to date. A 2022 Frontiers in Aging study found that NMN (600 mg/day for 60 days) improved physical performance metrics in middle-aged recreational runners. The 500–1,000 mg/day range used in most studies is consistent with current supplementation practice.
The NMN-insulin resistance connection is relevant: NMN’s best human evidence is in improving insulin sensitivity, not extending lifespan. This connects directly to the muscle mitochondrial dysfunction discussed in insulin resistance: why 40% of adults have it.
Apicagen and Quercetin: The Synergistic CD38 Inhibitors
A less-discussed but potentially important angle: CD38 inhibition. CD38 is the primary NAD+-consuming enzyme outside of PARP and sirtuins, and it is significantly upregulated with age and inflammation. Apigenin (a flavonoid found in parsley, chamomile, and celery) and quercetin both inhibit CD38 in vitro and animal studies. Reducing CD38-mediated NAD+ consumption may be as effective as precursor supplementation at normalizing cellular NAD+ — and both are inexpensive, have anti-inflammatory profiles, and come with the omega-3 / inflammation context of reducing chronic inflammation.
The Free Interventions That Raise NAD+ Most Effectively
This is the part that gets less attention in supplement marketing. The lifestyle interventions with the most evidence for raising tissue NAD+ and sirtuin activity:
Exercise
Exercise — particularly aerobic exercise and resistance training — is the most consistent NAD+ elevator in controlled studies. The mechanism: muscle contraction creates an energy demand that depletes ATP and increases the NAD+/NADH ratio, upregulating NAMPT (the rate-limiting enzyme in NAD+ biosynthesis) and increasing sirtuin activity. A 2022 Cell Metabolism paper found that aerobic training produces SIRT1 and SIRT3 activation comparable to NR supplementation at matched time points. The connection to Zone 2 training: Zone 2 specifically activates the SIRT1-PGC-1alpha axis that drives mitochondrial biogenesis — the same pathway NAD+ supplementation targets, at no cost.
Fasting and Time-Restricted Eating
Caloric restriction and fasting increase the NAD+/NADH ratio by reducing NADH production (less substrate entering the citric acid cycle) and by activating AMPK, which upregulates NAMPT. Intermittent fasting produces SIRT1 activation within 24 hours in human peripheral blood mononuclear cells. This is one mechanism by which time-restricted eating produces metabolic benefits beyond caloric restriction — reviewed in intermittent fasting: what the science actually shows.
Heat (Sauna) and Cold
Sauna exposure (15–20 minutes at 80–100°C) activates SIRT1 through heat shock factor 1 (HSF1) and increases NAMPT expression. A 2021 study in Cell found that repeated thermal stress activates mitochondrial unfolded protein response (UPRmt) pathways that overlap with NAD+/sirtuin-mediated longevity mechanisms. Cold exposure activates SIRT3 specifically (the mitochondrial sirtuin) through brown adipose tissue activation. Both are accessible, free, and have supporting cardiovascular and metabolic data independent of NAD+ biology.
Niacin (Vitamin B3)
Niacin is the simplest NAD+ precursor — it enters the biosynthesis pathway at the same step as nicotinamide and NMN but costs less than 1% of NMN supplements. At pharmacological doses (1,000–3,000 mg daily), niacin raises NAD+ significantly and has the longest clinical track record (it was used for lipid modification for 60 years before statins). The limitation at high doses is flushing — a prostaglandin-mediated skin response that some people find intolerable but is harmless. At 500 mg daily (below flushing threshold for most people), niacin provides a meaningful NAD+ precursor boost at minimal cost.
My Practical NAD+ Protocol
Based on the current evidence balance, here is how I approach NAD+ optimization — first with high-ROI lifestyle interventions, then with targeted supplementation:
- Foundation (do these first, they’re free): 150–200 min/week Zone 2 aerobic training, resistance training 3×/week, 16:8 time-restricted eating window, sauna 3–4×/week if accessible.
- Address inflammation (the CD38 NAD+ drain): Resolve chronic inflammation through omega-3, dietary fiber, and visceral fat reduction. An inflammatory state consumes NAD+ at a rate that precursor supplementation cannot overcome. See omega-3 dosing and chronic inflammation.
- Correct nutrient deficiencies that impair NAD+ synthesis: Magnesium (NAMPT requires magnesium), niacin (500 mg daily as nicotinic acid), and adequate tryptophan from protein (the de novo NAD+ synthesis pathway from tryptophan contributes approximately 20% of NAD+).
- NMN or NR supplementation (optional, for 40+): If you want to add a precursor after the above is in place — NMN 300–500 mg sublingual in the morning or NR 500–1,000 mg with breakfast. The sublingual NMN route bypasses the GI conversion step and may increase bioavailability. The evidence doesn’t strongly favor one over the other at this point.
- Apigenin or quercetin (CD38 inhibitor): 50–100 mg apigenin daily (from parsley extract or supplement) or 500–1,000 mg quercetin dihydrate with breakfast. Inexpensive, anti-inflammatory, and may reduce NAD+ consumption as effectively as increasing production.
Frequently Asked Questions
Is NMN safe?
The safety profile of NMN in human studies to date appears good. A 2020 safety study in npj Aging found that NMN at 250–1,250 mg/day for 4 weeks produced no clinically significant adverse effects in healthy adults. Longer-term safety data is limited by the relatively recent emergence of human trials. One theoretical concern: NAD+ supports DNA repair, but it also fuels rapidly dividing cells — meaning high-dose NAD+ supplementation in someone with occult malignancy is a theoretical (though unproven) concern. This is the reason I recommend addressing inflammatory and lifestyle drivers before adding high-dose precursor supplements.
Does NAD+ supplementation extend lifespan in humans?
No human longevity data exists yet. The animal data is impressive: NMN and NR extend lifespan in mice, reverse age-related muscle loss, improve cognitive function in aging mice, and restore fertility in aged mice. Whether these effects translate to humans at commercially available doses is unknown. We will have better answers in the next 5–10 years as the current cohort studies complete. My current view: the preclinical evidence is strong enough to justify supplementation as part of a comprehensive longevity protocol, but not strong enough to prioritize over the lifestyle interventions with established human data.
Should I take NMN with resveratrol?
Resveratrol was long promoted as a SIRT1 activator and NAD+ synergist. The human data for resveratrol has been disappointing: multiple clinical trials in humans have failed to show the metabolic and longevity benefits seen in animal models, and the bioavailability of standard resveratrol supplements is poor. If you are going to take a sirtuin activator alongside NMN, the evidence slightly favors pterostilbene (a methylated resveratrol analogue with better bioavailability) or fisetin (which also has senolytic properties) over standard resveratrol.
How does sleep affect NAD+ levels?
NAD+ has a strong circadian rhythm — it peaks during the active phase and troughs during sleep. Circadian disruption (shift work, late eating, irregular sleep schedules) dysregulates NAD+ oscillation and impairs sirtuin activity that depends on the daily NAD+ peak. Sleep deprivation reduces SIRT1 activity in white blood cells measurably within 3 days. This is another reason why sleep quality, cortisol management, and circadian alignment are the foundational interventions before any supplement. See sleep deprivation and chronic disease for the full metabolic impact picture.
The Bottom Line
The NAD+ biology is real. The age-related decline is real. The sirtuin and PARP mechanisms are real and important. What is less real than the supplement marketing suggests: the evidence that high-dose NMN or NR supplementation in healthy adults produces meaningful longevity benefit above what Zone 2 training, time-restricted eating, adequate sleep, and inflammation reduction already provide.
My protocol: build the lifestyle foundation first (exercise, fasting, sleep, inflammation), correct the nutritional gaps that impair NAMPT (magnesium, niacin, protein), then add NMN 300–500 mg sublingual in the morning if you are 40+ and want to add an evidence-based precursor. The CD38 inhibitors (apigenin, quercetin) are an underappreciated and inexpensive complement. Skip the resveratrol.
I test all of this on myself first. That is the honest truth.
For a personalized longevity protocol, reach me at health-consultation or browse the course library at health-courses.
Related Articles
- Zone 2 Training & Longevity: The Evidence
- Optimal Vitamin D Levels: What the Research Shows
- Biological Age Testing: Epigenetic Clocks
Dive Deeper
- Zone 2 Training: The Science-Backed Exercise for Longevity
- Sarcopenia: The Silent Muscle Loss That Starts at 30 (And How to Stop It)
- Autophagy and Fasting: The Science Behind Cellular Renewal
- Intermittent Fasting: The Evidence, the Mechanisms, and the Protocol
- Mitochondrial Dysfunction: Root Causes, Testing, and the Recovery Protocol